Infinium Pharmachem Limited IPO Detail
Incorporated in 2003, Infinium Pharmachem Limited manufactures & supplies Iodine Derivatives, APIs, and Iodination reaction-based bulk drugs.
The company offers R & D services and commercial scale manufacturing and packaging for Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals & other chemical industries.
Infinium Pharmachem's manufacturing plant is located in Gujarat - INDIA, which spans across 4100 Sq. Mtr. Plot area. The facility is FDA certified & GMP compliant with capabilities of producing complex Iodine Derivatives.
The company serves to over 15+ countries across the globe and has over 200+ Iodine Derivatives and 7+ APIs.
Company Promoters
Mr. Sanjaykumar Viththalbhai Patel, Mr. Pravin Bhadabhai Madhani, And Mr. Mitesh Lavjibhai ChikhaliyaIPO Details
| IPO Opening Date | Mar 31, 2023 |
| IPO Closing Date | Apr 05, 2023 |
| Issue Type | Fixed Price Issue IPO |
| Face Value | ₹10 per equity share |
| IPO Price | ₹135 per equity share |
| Market Lot | 1000 Shares |
| Min Order Quantity | 1000 Shares |
| Listing At | NSE SME |
| Issue Size | ₹25.31 Cr |
| Fresh Issue | ₹25.31 Cr |
| Offer for Sale | - |
| Retail Portion | 50% |
IPO Tentative Timetable
The Infinium Pharmachem Limited IPO open date is Mar 31, 2023, and the close date is Apr 05, 2023. The issue may list on Apr 17, 2023.
| IPO Open Date | Mar 31, 2023 |
| IPO Close Date | Apr 05, 2023 |
| Basis of Allotment Date | Apr 11, 2023 |
| Initiation of Refunds | Apr 12, 2023 |
| Credit of Shares to Demat Account | Apr 13, 2023 |
| IPO Listing Date | Apr 17, 2023 |
IPO Lot Size
The Infinium Pharmachem Limited IPO market lot size is 1000 shares. A retail-individual investor can apply for up to 1 lots (1000 shares or ₹135000).
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 1000 | ₹135000 |
| Maximum | 1 | 1000 | ₹135000 |
IPO Promoter Holding
| Pre Issue Share Holding | 100% |
| Post Issue Share Holding |
Company Financials:
For the year/period ended (₹ in Lakhs)
| Financial Year | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 31-Mar-20 | 2,244.60 | 3,941.64 | 93.40 |
| 31-Mar-21 | 3,418.27 | 7,115.37 | 272.48 |
| 31-Mar-22 | 5,899.95 | 10,005.25 | 610.64 |
| 30-Sep-22 | 7,075.71 | 7,985.39 | 551.01 |
Objects of the Issue:
The proceeds from the fresh issue will be utilized for the following objects:
1. Marketing and branding expenses (including registration in reach - Europe, and other marketing expenses).
2. Repayment of some of the existing loans and expansion of units.
3. To meet incremental working capital requirements.
4. To meet public issue expenses.
Infinium Pharmachem Limited IPO Registrar:
Bigshare Services Pvt Ltd
Infinium Pharmachem Limited IPO Lead Manager(s):
Swastika Investmart Ltd
Company Contact Information:
Infinium Pharmachem Limited
38 G.I.D.C Sojitra,
Taluka - Sojitra,
Dist. - Anand - 387240
